The trademark application STILLWATER was filed by Neurocrine Biosciences, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 7, 2021, and it was registered by office on October 14, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development services
Conducting clinical trials for pharmaceutical preparations
Conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
Pharmaceutical research and development services in the field of epilepsy and central nervous system diseases and disorders
Conducting clinical trials for pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders
Conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of epilepsy and central nervous system disease and disorders, and evaluating epidemiological results for treatments for epilepsy and central nervous system diseases and disorders
Providing research information to patients and practitioners as to the results of clinical trials
Providing research information to patients and practitioners as to the results of clinical trials pertaining to therapies and treatments for epilepsy and central nervous system diseases and disorders.
The mark was filed in class 44 with Providing medical information and providing medical information relating to therapies and treatments for epilepsy and central nervous system diseases and disorders..